EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Prospect of Gold Nanoparticles in Pancreatic Cancer

Tianyi Yin, Jingrun Han, Yuying Cui, Dong Shang, Hong Xiang iD

Pharmaceutics · 14.06.2024 · 16 (6) · 806

DOI: 10.3390/pharmaceutics16060806 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 14.06.2024. Verfasst von Tianyi Yin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer (PC) is characterized by its notably poor prognosis and high mortality rate, underscoring the critical need for advancements in its diagnosis and therapy. Gold nanoparticles (AuNPs), with their distinctive physicochemical characteristics, demonstrate significant application potential in cancer therapy. For example, upon exposure to lasers of certain wavelengths, they facilitate localized heating, rendering them extremely effective in photothermal therapy. Additionally, their extensive surface area enables the conjugation of therapeutic agents or targeting molecules, increasing the accuracy of drug delivery systems. Moreover, AuNPs can serve as radiosensitizers, enhancing the efficacy of radiotherapy by boosting the radiation absorption in tumor cells. Here, we systematically reviewed the application and future directions of AuNPs in the diagnosis and treatment of PC. Although AuNPs have advantages in improving diagnostic and therapeutic efficacy, as well as minimizing damage to normal tissues, concerns about their potential toxicity and safety need to be comprehensively evaluated.

Schlagwörter

Stichwörter der Autor:innen

diagnosisgold nanoparticlespancreatic cancersafetytherapy

Autor:innen und Institutionen

  • Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
  • Clinical Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
  • Institute of Integrative Medicine, Dalian Medical University, Dalian 116044, China.

ORCID-Profile: Hong Xiang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yin, T., Han, J., Cui, Y., Shang, D., & Xiang, H. (2024). Prospect of Gold Nanoparticles in Pancreatic Cancer. Pharmaceutics, 16(6), 806. https://doi.org/10.3390/pharmaceutics16060806

Vancouver

Yin T, Han J, Cui Y, Shang D, Xiang H. Prospect of Gold Nanoparticles in Pancreatic Cancer. Pharmaceutics. 2024;16(6):806. doi:10.3390/pharmaceutics16060806

BibTeX
@article{Yin2024,
  author = {Yin, Tianyi and Han, Jingrun and Cui, Yuying and Shang, Dong and Xiang, Hong},
  title = {Prospect of Gold Nanoparticles in Pancreatic Cancer},
  journal = {Pharmaceutics},
  year = {2024},
  volume = {16},
  number = {6},
  pages = {806},
  doi = {10.3390/pharmaceutics16060806}
}
Kostenlos starten →